Towards intrinsic R2* imaging in the prostate at 3 and 7tesla

Mariska P Luttje, Laurens D van Buuren, Peter R Luijten, Marco van Vulpen, Uulke A van der Heide, DWJ Klomp

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose Hypoxia is an important marker for resistance to therapy. In this study, we quantify the macroscopic effects of R2* mapping in prostate cancer patients incorporating susceptibility matching and field strengths effects. Materials and methods 91 patients were scanned without endorectal coil (ERC) at 3 T. Only when rectal gas was absent, data was included for analysis. Another group of 10 patients was scanned using a susceptibility matched ERC. To assess the residual contamination of R2 and macroscopic field non-uniformities, a group of 10 patients underwent ultra-high resolution 7 T MRI. Results Of the patients scanned at 3 T 60% presented rectal gas and were excluded, due to susceptibility artifacts. At 3 T the tumor was significantly different (P < 0.01) from the healthy surrounding tissue in R2* values at intrapatient level. Using the measured median R2* value of 24.9 s − 1 at 3 T and 43.2 s − 1 at 7 T of the peripheral zone, the minimum contribution of macroscopic susceptibility effects is 15% at 3 T. Conclusion R2* imaging might be a promising tool for hypoxia imaging, particularly when minimizing macroscopic susceptibility effects contaminating intrinsic R2* of tissue, such as rectal gas. At 3 T macroscopic effects still contribute 15% in the R2* value, compared to ultra-high resolution R2* mapping at 7 T.

Original languageEnglish
Pages (from-to)16-21
Number of pages6
JournalMagnetic Resonance Imaging
Volume42
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Bold
  • High field
  • Hypoxia
  • Prostate (cancer)
  • R2*

Fingerprint

Dive into the research topics of 'Towards intrinsic R2* imaging in the prostate at 3 and 7tesla'. Together they form a unique fingerprint.

Cite this